Steve Lamola

Steve Lamola currently serves as the Vice President of Clinical Development at Vaxcyte, a position held since December 2023. Prior to this role, Lamola was the Vice President of Clinical Development at HilleVax from February 2022 to August 2023. Lamola has extensive experience in the medical field, having worked as a Medical Officer at PATH from September 2013 to February 2022 and as a Clinical Investigator at Benaroya Research Institute from November 2012 to September 2013. Additionally, Lamola held dual roles as Associate Director of Clinical Research and Clinical Research Physician at Gilead Sciences between July 2007 and September 2012. Academic credentials include a Doctor of Medicine (MD) from the University of California, San Francisco - School of Medicine, obtained from 1999 to 2004, and a Bachelor of Arts from Yale University, earned in June 1989. Clinical and research expertise has been developed over years of dedicated service in the healthcare sector.